Page last updated: 2024-09-03

procyanidin b2 and Fatty Liver, Nonalcoholic

procyanidin b2 has been researched along with Fatty Liver, Nonalcoholic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, J; Jing, Y; Li, D; Liu, S; Peng, C; Peng, F; Qin, S; Zhong, K1
Chen, W; Hu, D; Ke, H; Li, Y; Su, H; Xie, L; Zheng, X1
Huang, MX; Jiang, Y; Lei, GT; Wu, QH; Xing, YW1

Reviews

1 review(s) available for procyanidin b2 and Fatty Liver, Nonalcoholic

ArticleYear
Procyanidin B2: A promising multi-functional food-derived pigment for human diseases.
    Food chemistry, 2023, Sep-15, Volume: 420

    Topics: Biflavonoids; Catechin; Functional Food; Humans; Non-alcoholic Fatty Liver Disease; Phosphatidylinositol 3-Kinases; Proanthocyanidins; Signal Transduction

2023

Other Studies

2 other study(ies) available for procyanidin b2 and Fatty Liver, Nonalcoholic

ArticleYear
Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Free radical biology & medicine, 2018, Volume: 126

    Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Biflavonoids; Catechin; Diet, High-Fat; Fatty Acids, Nonesterified; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Lipogenesis; Liver; Lysosomes; Metabolic Networks and Pathways; Mice; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidation-Reduction; Oxidative Stress; Proanthocyanidins

2018
Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease
    World journal of gastroenterology, 2019, Feb-28, Volume: 25, Issue:8

    Topics: Animals; Bacteroidetes; Biflavonoids; Biomarkers; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Insulin Resistance; Lipopolysaccharides; Liver; Male; Non-alcoholic Fatty Liver Disease; Obesity; Proanthocyanidins; Protective Agents; Rabbits; RNA, Ribosomal, 16S; Treatment Outcome; Triglycerides

2019